Immunology of major depression

Area of Science:

• Neuroscience
• Immunology
• Psychiatry

Background:

• Elevated proinflammatory cytokines (e.g., interleukin-6, C-reactive protein, tumor necrosis factor-α) are observed in major depression (MD).
• Inflammation is implicated in the pathophysiology of MD, affecting neurotransmitter systems.
• Cytokines influence neurotransmitter storage and release via microglia and astrocytes.

Purpose of the Study:

• To discuss the role of inflammation in the pathophysiology of major depression.
• To explore mechanisms linking inflammation to neurotransmitter alterations.
• To review epidemiological and therapeutic evidence supporting the inflammation-MD link.

Main Methods:

• Review of existing literature on inflammation markers in MD.
• Discussion of cytokine effects on tryptophan/kynurenine metabolism and neurotransmission.
• Analysis of epidemiological data and clinical studies on risk factors and treatments.

Main Results:

• Proinflammatory cytokines affect tryptophan metabolism, degrading serotonin.
• Neuroactive kynurenines (kynurenic and quinolinic acids) modulate glutamatergic neurotransmission.
• Low-level neuroinflammation is associated with altered serotonergic, noradrenergic, and glutamatergic systems.
• Severe infections and autoimmune disorders are identified as lifetime risk factors for MD.
• Anti-inflammatory medications and antidepressants demonstrate therapeutic benefits.

Conclusions:

• Inflammation plays a significant role in the pathophysiology and risk of major depression.
• Neuroinflammation contributes to neurotransmitter dysregulation implicated in MD symptoms.
• Targeting inflammatory pathways represents a potential therapeutic strategy for MD.